Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Getting More "Health," Less "Sickness" Into Marriage Vows
It"s June, the month when many couples promise to stay together "in sickness and in health."
generic viagra online
Medivation Selects ProTrials To Conduct International Phase III Clinical Trials
ProTrials Research, Inc.TM, a leader in the clinical research organization industry, announced Medivation, Inc. (NASDAQ:MDVN) has chosen the company to conduct separate international Phase III clinical trials for two novel treatments. ProTrials will test MDV3100 for treating prostate cancer and the investigational drug Dimebon TM as a treatment for Huntington"s disease. Due to the complex nature of these Phase III trials, Medivation again selected ProTrials as its contract research organization partner because of ProTrials" successful past performance with the company"s Phase I, II and III trials.
plastic surgery before after
News of the day
NCCN Updates Infection Guidelines To Include Information About H1N1 Virus (Swine Flu)
Infectious diseases are important causes of morbidity and mortality in patients with cancer. In certain cases, the malignancy itself can predispose patients to severe or recurrent infections. The National Comprehensive Cancer Network (NCCN) recognizes the importance of providing the latest information on treating these infections and has developed the NCCN Clinical Practice Guidelines in Oncology(TM) for the Prevention and Treatment of Cancer-Related Infections. The NCCN Guidelines were recently updated to include information about the effect that the H1N1 virus, or "swine flu," may have on the diagnosis and treatment of cancer treatment-related infections.
Health Insurance

Addictive 'Spice Gold' Causes Withdrawal Syndrome

A clinical report from Dresden supports the impression that "Spice Gold" is strongly addictive. In the current edition of Deutsches Arzteblatt International (Dtsch Arzteblatt Int 2009: 106[27]: 464-7), Ulrich S. Zimmermann, from Dresden Technical University, and his colleagues describe a young man who developed physical withdrawal symptoms after regular consumption of this designer drug, accompanied by a dependence syndrome. Since 22 January 2009, "Spice Gold" has been subject to the German Narcotics Law. This means that production, free trade and possession are forbidden - but initially for only a year. There will be a permanent regulation at the end of the year. More information about "Spice Gold" is currently being collected. The authors" case report is a scientific contribution to this discussion. When he came to the hospital, the patient had been consuming "Spice Gold" daily for eight months. Because of the loss of activity, he had rapidly increased the daily dose from 1 g to 3 g. He felt continuous craving for the drug and this caused him to carry on consuming it, in spite of the cognitive impairment it caused him. This led him to neglect his duties at his workplace and he was now threatened with unemployment. He had already been forced to be abstinent for a time, because of a bottleneck in supplies, and this had triggered typical withdrawal symptoms, such as internal unrest, tremor, palpitations, headache, nausea, vomiting, depression and desperation. These symptoms had abruptly disappeared when he started consuming spice once again. He suffered similar symptoms during drug withdrawal in hospital. The authors interpret the symptoms as indicating a typical withdrawal disease, very probably due to the admixture of synthetic cannabinomimetics. Dr. Stephan Mertens Deutsches Aerzteblatt International


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009